SBC welcomes ‘virtual scientists’ in first-of-its-kind AI partnership to speed UK biotech innovation
SBC welcomes ‘virtual scientists’ in first-of-its-kind AI partnership to speed [...]
A warm welcome to LifeArc’s new Industrial Placement (IP) students
LifeArc is pleased to welcome its newest cohort of Industrial [...]
Santo Therapeutics Raises Multi-Million (GBP-Equivalent) Round Led by FIRHealth Capital
Santo Therapeutics Raises Multi-Million (GBP-Equivalent) Round Led by FIRHealth Capital [...]
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into Opti-GAIN, a Phase I/II Clinical Trial in Geographic Atrophy secondary to AMD
Complement Therapeutics Receives FDA IND Clearance to Advance CTx001 into [...]
Aerska, a biotech focused on neurological disease, has chosen SBC as its UK base of lab operations
SBC is thrilled to announce that Aerska, a pioneering RNAi [...]
Neobe Therapeutics wins Pathfinder 2025 at Business Weekly 35th Anniversary Awards
Huge congratulations to SBC occupier Neobe Therapeutics on winning the [...]
NRG Therapeutics Announces £50m Series B Financing to Deliver Clinical Data in Parkinson’s and ALS/MND
NRG Therapeutics Announces Oversubscribed £50m ($67m) Series B Financing to [...]
Welcome RosettaPath to SBC’s Seed Works office!
We are delighted to welcome RosettaPath to our Seed Works [...]
PhD Student Opportunity at Entoplast
PhD Student Opportunity at Entoplast, a company that produces biopolymers [...]
First non-hormonal menopause treatment approved for use in the UK by the MHRA, with early-stage development at Stevenage Bioscience Catalyst
First non-hormonal menopause treatment in its class of drugs approved [...]
